Data refreshed:

Tender cb-572-47218385

Pralidoxime

In plain English

What it is
Pralidoxime
Who's buying
Department of National Defence (DND)
What they want
NOTICE OF PROPOSED PROCUREMENT The Department of National Defence (DND) through the Strategic Medical Countermeasures Program on behalf of the Canadian Forces Health Services Group, has a requirement for Pralidoxime for the treatment of Canadian Armed Forces (CAF) members suspected of exposure to chemical warfare agents. The initial requirement is for the delivery of 450 doses to be delivered before 31 March 2027. Optional requirements of 600 doses to be requested and delivered between 01 April 2027 and 31 March 2031. There are no security requirements associated with this requirement. The Cro…
Deadline
Nov 10, 2026, 14:00 UTC
How to bid
Submit through CanadaBuys before the deadline, following the instructions in the official notice. Method: Competitive - Open bidding.
Contact
Stephen Brown · [email protected] · (343) 630-0031

Notice details

Status
Open
Solicitation number
W6369-26-A033/B
Notice type
Request for Proposal
Published
Sep 24, 2026
Category (UNSPSC)
Drugs and pharmaceutical products
Regions of delivery
International

Similar open tenders

Past awards in this category

  • SO - Naloxone Nasal Spray - Emergent BioSolutions Canada Inc

    CW2464479

    Vendor
    Emergent BioSolutions Canada Inc.
    Value
    $3,000,000
    Awarded
    Aug 20, 2026
  • 21120-268734 Cystic Fibrosis Medications NISO

    CW2448497

    Vendor
    McKesson Canada Corporation
    Value
    $4,000,000
    Awarded
    Apr 10, 2026
  • K4E21-260484 REMOTE MEDICAL HEALTH CARE SUPPORT WITH MEDICAL SUPPLY KITS

    CW2441337

    Vendor
    PRAXES Medical Group
    Value
    $79,147
    Awarded
    Apr 9, 2026
  • Hepatitis B Vaccines Merck

    CW2447092

    Vendor
    Merck Canada Inc.
    Value
    $3,855,797
    Awarded
    Apr 1, 2026
  • Hepatitis B Vaccines GSK

    CW2447088

    Vendor
    GlaxoSmithKline Inc.
    Value
    $9,462,827
    Awarded
    Apr 1, 2026
  • Contract (GSK) - Supply Pertussis-containing vaccines

    CW2445891

    Vendor
    GlaxoSmithKline Inc.
    Value
    $29,400,277
    Awarded
    Mar 30, 2026

Get alerts for tenders like this

One free daily digest. No account needed. Unsubscribe any time.